Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Bogart
Real-World Effectiveness of Mepolizumab in Patients With Severe Asthma: An Examination of Exacerbations and Costs
Journal of Asthma and Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Related publications
Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Prs55 - Cost-Effectiveness of Mepolizumab in Severe Eosinophilic Asthma Patients in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Mepolizumab Improves Patient Outcomes and Reduces Exacerbations in Severe Asthma Patients With Comorbid Upper Airways Disease
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Cost Effectiveness of Mepolizumab in Adult Asthma Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Mepolizumab Reduces Exacerbations in Patients With Severe Eosinophilic Asthma, Irrespective of Body Weight/Body Mass Index: Meta-Analysis of MENSA and MUSCA
Respiratory Research
Pulmonary
Respiratory Medicine
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients With Moderate to Severe Asthma
Journal of Allergy and Clinical Immunology: In Practice
Allergy
Immunology
Patients With Severe Eosinophilic Asthma Treated With Mepolizumab: Results From Our Clinical Practice
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use With Omalizumab From the Real-World PROSPERO Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Asthma Control and Severe Exacerbations in Patients With Moderate or Severe Asthma in Jilin Province, China: A Multicenter Cross-Sectional Survey
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
